[Effects on the quality of life of a new oral contraceptive containing 30 mcg EE and 3 mg drospirenone (Yasmin)].
In a clinical multicenter observational study including 584 women attended by 99 participating gynaecologists the quality of life changes after 3 month use of an oral contraceptive preparation containing 30 mcg ethinylestradiol (EE) and 3 mg drospirenone was evaluated through the use of a self developed questionnaire using 20 items with a 5 scale answer scheme. We found a mean positive change of life quality of 7.3%. Significant changes were observed regarding subjective experiences of weight, skin, hair, cycle, attractivity, libido and mental wellbeing.
Bitzer
J
J
Abteilung für gynäkologische Sozialmedizin und Psychosomatik der Universitätsfrauenklinik Basel.
Tschudin
S
S
Meier-Burgoa
J
J
Armbruster
U
U
Schwendke
A
A
D000328:Adult; D000736:Androstenes / Q000008:administration & dosage; D001835:Body Weight; D003276:Contraceptives, Oral / Q000008:administration & dosage; D003627:Data Interpretation, Statistical; D004997:Ethinyl Estradiol / Q000008:administration & dosage; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007989:Libido; D008598:Menstruation; D045167:Progesterone Congeners / Q000008:administration & dosage; D011788:Quality of Life; D011795:Surveys and Questionnaires; D013997:Time Factors
D000736:Androstenes; D003276:Contraceptives, Oral; D045167:Progesterone Congeners; D004997:Ethinyl Estradiol; C035144:drospirenone